MetaADEDB 2.0 @ LMMD
cabozantinib
(ONIQOQHATWINJY-UHFFFAOYSA-N)
Structure
SMILES
COc1cc2c(ccnc2cc1OC)Oc1ccc(cc1)NC(=O)C1(CC1)C(=O)Nc1ccc(cc1)F
Type(s)
Approved; Investigational
ATC code(s)
L01XE26
Molecular Formula:
C28H24FN3O5
Molecular Weight:
501.506
Log P:
5.6868
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
2
TPSA:
98.78
CAS Number(s):
849217-68-1
Synonym(s)
1.
cabozantinib
2.
BMS 907351
3.
BMS-907351
4.
BMS907351
5.
Cometriq
6.
XL 184
7.
XL-184
8.
XL184 cpd
External Link(s)
MeSHC558660
PubChem Compound25102847
BindingDB50021574
ChEBI72317
CHEMBLCHEMBL2105717
DrugBankDB08875
DrugCentral4715
IUPHAR/BPS Guide to PHARMACOLOGY5887
KEGGdr:D10062
Therapeutic Target DatabaseD0IQ6P
ZINC70466416
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1FatigueFAERS: 163
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
2NauseaFAERS: 111
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
3AstheniaFAERS: 73SIDER
US FAERS
4Malignant neoplasm progressionFAERS: 67
Canada Vigilance: 6
Canada Vigilance
US FAERS
5StomatitisFAERS: 63
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
6VomitingFAERS: 62
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
7Weight decreasedFAERS: 51
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
8PainFAERS: 50US FAERS
9DizzinessFAERS: 47SIDER
US FAERS
10MalaiseFAERS: 44US FAERS
11DysphoniaFAERS: 41SIDER
US FAERS
12DysgeusiaFAERS: 40SIDER
US FAERS
13Oral painFAERS: 40SIDER
US FAERS
14DehydrationFAERS: 36SIDER
US FAERS
15ConstipationFAERS: 32
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
16Skin UlcerFAERS: 30SIDER
US FAERS
17HeadacheFAERS: 29SIDER
US FAERS
18Oropharyngeal painFAERS: 29SIDER
US FAERS
19Dry skinFAERS: 25
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
20PneumoniaFAERS: 23
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
21AgeusiaFAERS: 21SIDER
US FAERS
22Abdominal PainFAERS: 20SIDER
US FAERS
23SepsisFAERS: 19
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
24ErythemaFAERS: 18
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
25Abdominal discomfortFAERS: 17US FAERS
26General physical health deteriorationFAERS: 15US FAERS
27Peripheral swellingFAERS: 15US FAERS
28PneumothoraxFAERS: 15SIDER
US FAERS
29DyspepsiaFAERS: 14SIDER
US FAERS
30PruritusFAERS: 14US FAERS
31ArthralgiaFAERS: 13
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
32Back PainFAERS: 13US FAERS
33Urinary tract infectionFAERS: 13US FAERS
34AlopeciaFAERS: 12
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
35Chest PainFAERS: 12US FAERS
36Blood creatinine increasedFAERS: 11US FAERS
37Burning sensationFAERS: 11US FAERS
38MyalgiaFAERS: 11US FAERS
39SomnolenceFAERS: 11US FAERS
40AnxietyFAERS: 10SIDER
US FAERS
41Pulmonary EmbolismFAERS: 10SIDER
US FAERS
42HypotensionFAERS: 9
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
43Memory impairmentFAERS: 9US FAERS
44Respiratory FailureFAERS: 9SIDER
US FAERS
45Cerebrovascular accidentFAERS: 8US FAERS
46Musculoskeletal PainFAERS: 8US FAERS
47ThrombocytopeniaFAERS: 8SIDER
US FAERS
48Tongue discomfortFAERS: 8US FAERS
49AcneFAERS: 7US FAERS
50Alanine Aminotransferase IncreasedFAERS: 7SIDER
US FAERS
51EmbolismFAERS: 7SIDER
US FAERS
52EpistaxisFAERS: 7US FAERS
53Febrile NeutropeniaFAERS: 7US FAERS
54HyperkeratosisFAERS: 7SIDER
US FAERS
55Skin lesionFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
56Acute kidney injuryFAERS: 6US FAERS
57AscitesFAERS: 6US FAERS
58Aspartate Aminotransferase IncreasedFAERS: 6SIDER
US FAERS
59Drug ineffective for unapproved indicationFAERS: 6US FAERS
60FlatulenceFAERS: 6US FAERS
61NasopharyngitisFAERS: 6US FAERS
62Non-cardiac chest painFAERS: 6US FAERS
63ThrombosisFAERS: 6US FAERS
64Atrial FibrillationFAERS: 5SIDER
US FAERS
65Blood alkaline phosphatase increasedFAERS: 5SIDER
US FAERS
66BronchitisFAERS: 5US FAERS
67CellulitisFAERS: 5US FAERS
68CholecystitisFAERS: 5US FAERS
69Deep Vein ThrombosisFAERS: 5US FAERS
70Drug ineffectiveFAERS: 5
Canada Vigilance: 5
Canada Vigilance
US FAERS
71Failure to ThriveFAERS: 5US FAERS
72HypersomniaFAERS: 5US FAERS
73HypophagiaFAERS: 5US FAERS
74HypothyroidismFAERS: 5SIDER
US FAERS
75LethargyFAERS: 5US FAERS
76Limb discomfortFAERS: 5US FAERS
77Lower respiratory tract infectionFAERS: 5US FAERS
78Musculoskeletal chest painFAERS: 5SIDER
US FAERS
79Myocardial InfarctionFAERS: 5US FAERS
80PancytopeniaFAERS: 5US FAERS
81Sinus TachycardiaFAERS: 5US FAERS
82SyncopeFAERS: 5US FAERS
83Tooth ExtractionFAERS: 5US FAERS
84Amylase increasedFAERS: 4US FAERS
85AphagiaFAERS: 4US FAERS
86AphoniaFAERS: 4US FAERS
87Blood urine presentFAERS: 4US FAERS
88Bone painFAERS: 4US FAERS
89CystitisFAERS: 4US FAERS
90DeliriumFAERS: 4SIDER
US FAERS
91Dermatitis acneiformFAERS: 4US FAERS
92Disease ProgressionFAERS: 4SIDER
US FAERS
93Feeling abnormalFAERS: 4SIDER
US FAERS
94Gamma-Glutamyltransferase IncreasedFAERS: 4US FAERS
95HypoxiaFAERS: 4US FAERS
96InfluenzaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
97Intestinal ObstructionFAERS: 4US FAERS
98LacerationFAERS: 4US FAERS
99LaryngitisFAERS: 4US FAERS
100LeukopeniaFAERS: 4US FAERS
101Lipase increasedFAERS: 4SIDER
US FAERS
102LymphopeniaFAERS: 4SIDER
US FAERS
103Pain of skinFAERS: 4US FAERS
104Pericardial effusionFAERS: 4US FAERS
105ProteinuriaFAERS: 4SIDER
US FAERS
106RetchingFAERS: 4US FAERS
107SinusitisFAERS: 4US FAERS
108SwellingFAERS: 4US FAERS
109ToothacheFAERS: 4US FAERS
110Toxicity to various agentsFAERS: 4US FAERS
111Unevaluable eventFAERS: 4US FAERS
112AbasiaFAERS: 3US FAERS
113Adverse eventFAERS: 3US FAERS
114Anal abscessFAERS: 3US FAERS
115AphasiaFAERS: 3US FAERS
116Cardiac ArrestFAERS: 3SIDER
US FAERS
117Chest discomfortFAERS: 3US FAERS
118Clostridium difficile infectionFAERS: 3US FAERS
119ColitisFAERS: 3US FAERS
120DeafnessFAERS: 3SIDER
US FAERS
121DisorientationFAERS: 3US FAERS
122Drug administration errorFAERS: 3US FAERS
123Drug dose omissionFAERS: 3US FAERS
124DysuriaFAERS: 3SIDER
US FAERS
125EnteritisFAERS: 3US FAERS
126Enterococcal sepsisFAERS: 3US FAERS
127Erythema MultiformeFAERS: 3US FAERS
128GlossitisFAERS: 3US FAERS
129GoutFAERS: 3US FAERS
130HepatotoxicityFAERS: 3US FAERS
131Herpes Zoster OticusFAERS: 3US FAERS
132InfectionFAERS: 3SIDER
US FAERS
133InflammationFAERS: 3US FAERS
134Joint swellingFAERS: 3US FAERS
135Liver AbscessFAERS: 3US FAERS
136MalnutritionFAERS: 3SIDER
US FAERS
137Musculoskeletal stiffnessFAERS: 3US FAERS
138NeuralgiaFAERS: 3US FAERS
139PeriodontitisFAERS: 3US FAERS
140Portal Vein ThrombosisFAERS: 3US FAERS
141Productive CoughFAERS: 3US FAERS
142Septic ShockFAERS: 3US FAERS
143Sinus headacheFAERS: 3US FAERS
144Skin reactionFAERS: 3US FAERS
145TachycardiaFAERS: 3US FAERS
146Throat irritationFAERS: 3US FAERS
147ThrombophlebitisFAERS: 3US FAERS
148Tooth LossFAERS: 3US FAERS
149White blood cell count decreasedFAERS: 3US FAERS
150Wound dehiscenceFAERS: 3US FAERS
151Abdominal InfectionFAERS: 2US FAERS
152AmnesiaFAERS: 2US FAERS
153Anal UlcerFAERS: 2US FAERS
154Anal inflammationFAERS: 2SIDER
US FAERS
155Angina PectorisFAERS: 2SIDER
US FAERS
156Anorectal infectionFAERS: 2US FAERS
157ArthritisFAERS: 2US FAERS
158Back disorderFAERS: 2US FAERS
159Blood calcitonin increasedFAERS: 2US FAERS
160Blood creatine phosphokinase increasedFAERS: 2US FAERS
161Blood magnesium decreasedFAERS: 2US FAERS
162Blood pressure fluctuationFAERS: 2US FAERS
163Blood thyroid stimulating hormone increasedFAERS: 2SIDER
US FAERS
164Bronchial ObstructionFAERS: 2US FAERS
165CachexiaFAERS: 2US FAERS
166Calcium deficiencyFAERS: 2US FAERS
167Cardiac TamponadeFAERS: 2US FAERS
168CheilitisFAERS: 2SIDER
US FAERS
169ChromaturiaFAERS: 2US FAERS
170Coating in mouthFAERS: 2US FAERS
171CryingFAERS: 2US FAERS
172DiverticulitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
173DysarthriaFAERS: 2US FAERS
174DysbacteriosisFAERS: 2US FAERS
175Ear discomfortFAERS: 2US FAERS
176EpilepsyFAERS: 2US FAERS
177Exposed bone in jawFAERS: 2US FAERS
178Flank PainFAERS: 2US FAERS
179FractureFAERS: 2US FAERS
180GastritisFAERS: 2US FAERS
181Genital rashFAERS: 2US FAERS
182HyperchlorhydriaFAERS: 2US FAERS
183HypersensitivityFAERS: 2US FAERS
184HypogeusiaFAERS: 2US FAERS
185IleusFAERS: 2US FAERS
186Intestinal PerforationFAERS: 2US FAERS
187Irritable Bowel SyndromeFAERS: 2US FAERS
188Mental impairmentFAERS: 2US FAERS
189Metabolic acidosisFAERS: 2US FAERS
190Neck PainFAERS: 2US FAERS
191NeutropeniaFAERS: 2SIDER
US FAERS
192Neutrophil count decreasedFAERS: 2SIDER
US FAERS
193Night sweatsFAERS: 2US FAERS
194NoduleFAERS: 2US FAERS
195Noninfective gingivitisFAERS: 2US FAERS
196Oral infectionFAERS: 2US FAERS
197PallorFAERS: 2SIDER
US FAERS
198PalpitationsFAERS: 2US FAERS
199Pancreatic PseudocystFAERS: 2US FAERS
200Performance status decreasedFAERS: 2US FAERS
201PharyngitisFAERS: 2US FAERS
202Pleuritic painFAERS: 2US FAERS
203Posterior reversible encephalopathy syndromeFAERS: 2SIDER
US FAERS
204Product use complaintFAERS: 2US FAERS
205Quality of life decreasedFAERS: 2US FAERS
206Rash erythematousFAERS: 2US FAERS
207Renal painFAERS: 2US FAERS
208Respiratory tract congestionFAERS: 2US FAERS
209ScabFAERS: 2US FAERS
210Seizure like phenomenaFAERS: 2US FAERS
211Skin hypertrophyFAERS: 2US FAERS
212SluggishnessFAERS: 2US FAERS
213Sudden deathFAERS: 2US FAERS
214SunburnFAERS: 2US FAERS
215Tongue eruptionFAERS: 2US FAERS
216Toxic Shock SyndromeFAERS: 2US FAERS
217TremorFAERS: 2SIDER
US FAERS
218VertigoFAERS: 2US FAERS
219Visual ImpairmentFAERS: 2US FAERS
220Vocal Cord ParalysisFAERS: 2US FAERS
221Wound InfectionFAERS: 2US FAERS
222AbscessFAERS: 1SIDER
US FAERS
223Acute Coronary SyndromeFAERS: 1US FAERS
224Acute myocardial infarctionFAERS: 1US FAERS
225Acute respiratory failureFAERS: 1US FAERS
226AlbinismFAERS: 1US FAERS
227Ammonia increasedFAERS: 1US FAERS
228Anal FissureFAERS: 1SIDER
US FAERS
229Anorectal discomfortFAERS: 1US FAERS
230Aphthous StomatitisFAERS: 1US FAERS
231AppendicitisFAERS: 1US FAERS
232ArteriosclerosisFAERS: 1US FAERS
233Aspergillus test positiveFAERS: 1US FAERS
234AsthenopiaFAERS: 1US FAERS
235AtaxiaFAERS: 1SIDER
US FAERS
236Biliary dilatationFAERS: 1US FAERS
237Blood albumin decreasedFAERS: 1US FAERS
238Blood blisterFAERS: 1US FAERS
239Blood calcium abnormalFAERS: 1US FAERS
240Blood electrolytes abnormalFAERS: 1US FAERS
241Blood glucose decreasedFAERS: 1US FAERS
242Blood glucose increasedFAERS: 1US FAERS
243Blood potassium decreasedFAERS: 1US FAERS
244Bone lesionFAERS: 1US FAERS
245Bronchopleural FistulaFAERS: 1US FAERS
246Budd-Chiari SyndromeFAERS: 1US FAERS
247BursitisFAERS: 1US FAERS
248Cancer PainFAERS: 1US FAERS
249Capillary Leak SyndromeFAERS: 1US FAERS
250Cataract operationFAERS: 1US FAERS
251ChillsFAERS: 1SIDER
US FAERS
252ChokingFAERS: 1US FAERS
253CholangitisFAERS: 1US FAERS
254CholelithiasisFAERS: 1SIDER
US FAERS
255CholestasisFAERS: 1US FAERS
256ClaustrophobiaFAERS: 1US FAERS
257ClonusFAERS: 1US FAERS
258Colonic fistulaFAERS: 1US FAERS
259Complication associated with deviceFAERS: 1US FAERS
260CyanosisFAERS: 1US FAERS
261CystFAERS: 1US FAERS
262Dental cariesFAERS: 1US FAERS
263Dental prosthesis placementFAERS: 1US FAERS
264Depressed Level of ConsciousnessFAERS: 1US FAERS
265Depressed moodFAERS: 1US FAERS
266DermatomyositisFAERS: 1US FAERS
267Dermo-hypodermitisFAERS: 1US FAERS
268Diabetes MellitusFAERS: 1US FAERS
269DiscomfortFAERS: 1US FAERS
270Disseminated Intravascular CoagulationFAERS: 1US FAERS
271Drug dispensing errorFAERS: 1US FAERS
272Drug prescribing errorFAERS: 1US FAERS
273Ejection Fraction DecreasedFAERS: 1US FAERS
274Electrolyte imbalanceFAERS: 1US FAERS
275Emotional disorderFAERS: 1US FAERS
276EmpyemaFAERS: 1US FAERS
277Enterococcal infectionFAERS: 1US FAERS
278EnterocolitisFAERS: 1US FAERS
279Exposure via body fluidFAERS: 1US FAERS
280Eye painFAERS: 1US FAERS
281FasciitisFAERS: 1US FAERS
282Feeling ColdFAERS: 1US FAERS
283Fluid imbalanceFAERS: 1US FAERS
284FlushingFAERS: 1US FAERS
285FolliculitisFAERS: 1SIDER
US FAERS
286Full blood count decreasedFAERS: 1US FAERS
287Gait inabilityFAERS: 1US FAERS
288GangreneFAERS: 1US FAERS
289Gastric pH decreasedFAERS: 1US FAERS
290Gastric ulcerFAERS: 1US FAERS
291Gastroenteritis norovirusFAERS: 1US FAERS
292Gastrointestinal infectionFAERS: 1US FAERS
293Gastrointestinal sounds abnormalFAERS: 1US FAERS
294Gastrointestinal toxicityFAERS: 1US FAERS
295GingivitisFAERS: 1US FAERS
296GlomerulonephritisFAERS: 1US FAERS
297Groin infectionFAERS: 1US FAERS
298Head discomfortFAERS: 1US FAERS
299HemiparesisFAERS: 1US FAERS
300Hepatic EncephalopathyFAERS: 1SIDER
US FAERS
301Hepatitis CFAERS: 1US FAERS
302HepatitisFAERS: 1US FAERS
303Hospice CareFAERS: 1US FAERS
304HydronephrosisFAERS: 1US FAERS
305HyperthyroidismFAERS: 1US FAERS
306Incision site painFAERS: 1US FAERS
307IncontinenceFAERS: 1US FAERS
308Incorrect dose administeredFAERS: 1US FAERS
309Initial insomniaFAERS: 1US FAERS
310Iron deficiencyFAERS: 1US FAERS
311Klebsiella test positiveFAERS: 1US FAERS
312Lack of spontaneous speechFAERS: 1US FAERS
313Large intestine perforationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
314LeukocytosisFAERS: 1US FAERS
315Limb injuryFAERS: 1US FAERS
316LymphangitisFAERS: 1US FAERS
317Macular degenerationFAERS: 1US FAERS
318Medication ErrorFAERS: 1US FAERS
319MenorrhagiaFAERS: 1US FAERS
320Mental status changesFAERS: 1US FAERS
321MetastasisFAERS: 1US FAERS
322Mood swingsFAERS: 1US FAERS
323Mouth swellingFAERS: 1US FAERS
324Mucosal indurationFAERS: 1US FAERS
325Nail InfectionFAERS: 1US FAERS
326Nasal discomfortFAERS: 1US FAERS
327NephritisFAERS: 1US FAERS
328NephrolithiasisFAERS: 1US FAERS
329Nephrotic SyndromeFAERS: 1US FAERS
330Obstructive nephropathyFAERS: 1US FAERS
331OligodipsiaFAERS: 1US FAERS
332Oral candidiasisFAERS: 1US FAERS
333Oral fungal infectionFAERS: 1US FAERS
334Oral mucosal eruptionFAERS: 1US FAERS
335Oral mucosal erythemaFAERS: 1US FAERS
336OsteomyelitisFAERS: 1US FAERS
337OverdoseFAERS: 1US FAERS
338Palmar erythemaFAERS: 1US FAERS
339PancreatectomyFAERS: 1US FAERS
340PancreatitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
341Paranasal sinus discomfortFAERS: 1US FAERS
342Paranasal sinus hypersecretionFAERS: 1US FAERS
343ParesisFAERS: 1US FAERS
344Pelvic PainFAERS: 1US FAERS
345Pelvic venous thrombosisFAERS: 1US FAERS
346Penile blisterFAERS: 1US FAERS
347PeritonitisFAERS: 1US FAERS
348Personality ChangeFAERS: 1US FAERS
349Pleural InfectionFAERS: 1US FAERS
350PleurisyFAERS: 1US FAERS
351PneumonitisFAERS: 1US FAERS
352PneumoperitoneumFAERS: 1US FAERS
353Poor dental conditionFAERS: 1US FAERS
354Poor quality sleepFAERS: 1US FAERS
355Portal HypertensionFAERS: 1US FAERS
356Post procedural hypothyroidismFAERS: 1US FAERS
357PresyncopeFAERS: 1US FAERS
358Product prescribing issueFAERS: 1US FAERS
359Protein total abnormalFAERS: 1US FAERS
360PsoriasisFAERS: 1US FAERS
361Psychological TraumaFAERS: 1US FAERS
362Pulmonary HypertensionFAERS: 1US FAERS
363Pulmonary painFAERS: 1US FAERS
364Radiation inflammationFAERS: 1US FAERS
365Rectal abscessFAERS: 1US FAERS
366Rectal dischargeFAERS: 1US FAERS
367Rectal fissureFAERS: 1US FAERS
368Renal Cell CarcinomaFAERS: 1US FAERS
369Retinal DetachmentFAERS: 1US FAERS
370RetinoschisisFAERS: 1US FAERS
371Saliva alteredFAERS: 1US FAERS
372Salmonella sepsisFAERS: 1US FAERS
373Secretion dischargeFAERS: 1US FAERS
374Skin PapillomaFAERS: 1US FAERS
375Skin discomfortFAERS: 1US FAERS
376Skin irritationFAERS: 1US FAERS
377Squamous cell carcinoma of skinFAERS: 1US FAERS
378Squamous cell carcinomaFAERS: 1US FAERS
379StenosisFAERS: 1US FAERS
380Stoma site ulcerFAERS: 1US FAERS
381Supraventricular tachycardiaFAERS: 1SIDER
US FAERS
382Teeth brittleFAERS: 1US FAERS
383Therapy cessationFAERS: 1US FAERS
384Thermal burnFAERS: 1US FAERS
385Thyroid NeoplasmFAERS: 1US FAERS
386Tympanic Membrane PerforationFAERS: 1US FAERS
387Upper respiratory fungal infectionFAERS: 1US FAERS
388Urine flow decreasedFAERS: 1US FAERS
389Vaginal PerforationFAERS: 1US FAERS
390Vascular ruptureFAERS: 1US FAERS
391VasculitisFAERS: 1US FAERS
392Wheelchair userFAERS: 1US FAERS
393WheezingFAERS: 1US FAERS
394Wrong technique in product usage processFAERS: 1US FAERS
395Activated partial thromboplastin time shortenedSIDER
396Arterial thrombosisSIDER
397AspergillomaSIDER
398AtelectasisSIDER
399Blood lactate dehydrogenase increasedSIDER
400CataractSIDER
401ConjunctivitisSIDER
402DermatitisSIDER
403Ear and labyrinth disordersSIDER
404Facial PainSIDER
405Gastrointestinal PainSIDER
406Gastrointestinal perforationSIDER
407InfestationSIDER
408Lactic dehydrogenase activity increasedSIDER
409LeukodermaSIDER
410Malignant HypertensionSIDER
411Musculoskeletal discomfortSIDER
412No adverse eventCanada Vigilance: 2Canada Vigilance
413Osteonecrosis of JawSIDER
414PrehypertensionSIDER
415Protein urine presentSIDER
416RhabdomyolysisSIDER
417Right Ventricular HypertrophyCanada Vigilance: 1Canada Vigilance
418SepticemiaSIDER
419Stevens-Johnson SyndromeCanada Vigilance: 1Canada Vigilance
420ThrombocytosisSIDER
421TinnitusSIDER
422Tracheal fistulaSIDER
423Venous ThrombosisSIDER
424nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.